Last quarter, we also learned that the protein MAdCAM-1 could become a prognostic biomarker in patients with kidney cancer, that a targeted therapy can be effective across several cancer types, that hormone therapy is more effective when combined with other treatments, and that a rare form of lung cancer (RET mutation) is sensitive to a new...

On 28 May, teams from the Department of Anaesthesia, Surgery and Interventional Procedures performed the 60th endoscopic mastectomy at Gustave Roussy. This technique, carried out under continuous visual guidance using a camera, enables the removal of the breast through a very short incision, thereby improving the aesthetic outcomes of breast...

The American Society of Clinical Oncology (ASCO) Annual Meeting is one of the leading global events in cancer research, held each year in Chicago, United States. Experts from Gustave Roussy contributed to 107 presentations featured in the 2026 programme, with a particular focus on antibody–drug conjugates (ADCs), a rapidly expanding field across...

Following several pioneering procedures carried out in 2025 on the colon, pharynx and liver, the teams from the Department of Anaesthesia, Surgery and Interventional Medicine (DACI) at Gustave Roussy are continuing to drive innovation in robotic surgery. Using the da Vinci Single Port system, they successfully removed a patient’s diseased...